Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Preliminary phase I data for the long-acting HIV capsid inhibitor GS-6207

July 25, 2019

Merck & Co. presents clinical data for MK-8591 in patients with HIV-1 infection

July 25, 2019

Gilead presents data on TLR7 agonists vesatolimod and GS-986

July 24, 2019

Dolutegravir recommended by WHO for first-line and second-line treatment for HIV

July 23, 2019

New assays mean new insights into HIV reservoir

July 23, 2019

At HIV Science meeting, lively discussion on what a cure will take

July 22, 2019

New public-private partnership to support phase III trial of Janssen's mosaic-based HIV vaccine

July 16, 2019

Merck & Co., Idenix Pharmaceuticals describe HIV-1 reverse transcriptase/ribonuclease H inhibitors

July 8, 2019

GlaxoSmithKline identifies new IDO1 inhibitors for HIV infection

July 4, 2019

European Commission approves Dovato for HIV-1 infection

July 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...